Strategies to Enable Remote Ingestion Monitoring, Patient Retention, and Quality Data
COVID-19 has resulted in suspensions of an unprecedented number of clinical trials. Remote trials can be enabled with digital technologies that provide assurance with real-time adherence monitoring and high-quality, real-world medication-taking data. Learn how these technologies have been used in trials to date and how they can address risks to the success of trials that are associated with poor adherence, distracted participants (or suboptimal participant engagement) and inaccurate adherence reporting.
Date:
June 25, 2020
Time:
1:00pm EST
Panelists:
Scott Ballenger
President, Locksmith Advisors
Peter R Chai MD MMS
Emergency Medicine, Medical Toxicology at Brigham and Women’s Hospital
Susan Baumgartner, PharmD, MBA
Vice President, Product Management & Regulatory Affairs, etectRx, Inc.
Stefanie Kuhner
Global Director – Clinical Technology & Patient Recruitment, Bristol Myers Squibb
